=== МЕТАДАННЫЕ ===
{
  "original_filename": "Regulation of Insulin Transcytosis Across Endothelium in Metabolic Health and Disease _ Arteriosclerosis, Thrombosis, and Vascular Biology.html",
  "converted_date": "2026-01-31T14:51:23.748281",
  "file_size_bytes": 681860,
  "original_format": "html",
  "document_type": "Articles",
  "source_folder": "Articles",
  "full_path": "00_RAW_CARDIOLOGY/Articles/Regulation of Insulin Transcytosis Across Endothelium in Metabolic Health and Disease _ Arteriosclerosis, Thrombosis, and Vascular Biology.html"
}

=== СОДЕРЖАНИЕ ===
Regulation of Insulin Transcytosis Across Endothelium in Metabolic Health and Disease | Arteriosclerosis, Thrombosis, and Vascular Biology
Skip to main content
Advertisement
Become a memberVolunteerDonate
JournalsBrowseCollectionsSubjectsAHA Journal PodcastsTrend WatchResourcesCMEAHA Journals @ MeetingsJournal MetricsEarly Career ResourcesInformationFor AuthorsFor ReviewersFor SubscribersFor International UsersAlerts
Shopping cart with
0
item
Cart
Search
Sign in
REGISTER
Quick Search in JournalsEnter search termQuick Search anywhereEnter search termQuick search in CitationsJournalYearVolumeIssuePageSearching:This JournalThis JournalAnywhereCitation
Advanced Search
Search
navigate the sidebar menu
Sign in
REGISTER
Quick Search anywhereEnter search term
Publications
Arteriosclerosis, Thrombosis, and Vascular Biology
Current Issue
Archive
Journal Information
About ATVB
Author
Instructions
Editorial
Board
Meet the Editors
Information for
Advertisers
Features
ATVB_net Blog
ATVB In Focus
Lecture Series
Reviews
Early Career
Resources
ATVB Journal
Awards
Circulation
Circulation Research
Hypertension
Stroke
Journal of the American Heart Association
Circulation: Arrhythmia and Electrophysiology
Circulation: Cardiovascular Imaging
Circulation: Cardiovascular Interventions
Circulation: Population Health and Outcomes
Circulation: Genomic and Precision Medicine
Circulation: Heart Failure
Stroke: Vascular and Interventional Neurology
Annals of Internal Medicine: Clinical Cases
Information
For Authors
For Reviewers
For Subscribers
For International Users
Submit & Publish
Submit to the AHA
Editorial Policies
Open Science
Value of Many Voices
Publishing with the AHA
Open Access Information
Resources
AHA Journals CME
AHA Journals @ Meetings
Metrics
AHA Journals Podcast Network
Early Career Resources
Trend Watch
Professional Heart Daily
AHA Newsroom
Current Issue
Archive
Journal Information
About ATVB
Author
Instructions
Editorial
Board
Meet the Editors
Information for
Advertisers
Features
ATVB_net Blog
ATVB In Focus
Lecture Series
Reviews
Early Career
Resources
ATVB Journal
Awards
Submit
Reference #1
Review ArticleOriginally Published 4 December 2025Regulation of Insulin Transcytosis Across Endothelium in Metabolic Health and DiseaseChieko Mineo https://orcid.org/0000-0002-4978-6177 and Philip W. Shaul https://orcid.org/0000-0003-1157-4002 philip.shaul@utsouthwestern.eduAuthor Info & AffiliationsArteriosclerosis, Thrombosis, and Vascular BiologyVolume 46, Number 2https://doi.org/10.1161/ATVBAHA.125.321545
189MetricsTotal Downloads189Last 12 Months189View all metrics
Track CitationsAdd to favorites
Get AccessContentsAbstractGraphical AbstractReferenceseLettersInformation & AuthorsMetrics & CitationsGet AccessReferencesFiguresTablesMediaShareAbstractThe delivery of insulin to the skeletal muscle has a major influence on glucose disposal in muscle, where 80% of total body glucose disposal occurs. The skeletal muscle microvascular endothelial cells play a critical role in peripheral insulin sensitivity through their regulation of insulin delivery. Recent advancements in methodologies have provided in-depth views of the molecular mechanisms by which the endothelial cells regulate the delivery process. However, how the cellular machinery is modulated under physiological or pathological conditions remains largely unexplored. Conditions with estrogen deficiency and obesity are 2 situations that are closely associated with peripheral insulin resistance and type 2 diabetes in humans. It is of great interest to determine whether and how endothelial control of insulin delivery impacts the development of metabolic dysregulation under these and other conditions. This review aims to provide an overview of the molecular mechanisms governing insulin delivery to the skeletal muscle. The available evidence will be presented that the transcytosis of insulin across the endothelial cell monolayer in skeletal muscle plays a critical role in muscle insulin delivery, thereby having a major impact on overall glucose homeostasis. In vivo investigations with manipulation of mechanisms in endothelial cells will be summarized, and the current knowledge gaps will be presented. Interrogation of the role of the endothelium in insulin transport provides a paradigm in which insights are being gained about cellular actions of insulin, molecular transport by endothelial cells, and the intricacies of glucose homeostasis.Graphical AbstractOpen in ViewerGet full access to this articleView all available purchase options and get full access to this article.Get AccessAlready a Subscriber? Sign in as an individual or via your institutionReferences1.Roden M, Shulman GI. The integrative biology of type 2 diabetes. Nature. 2019;576:51–60. doi: 10.1038/s41586-019-1797-8CrossrefPubMedGoogle Scholar2.Lawal Y, Bello F, Kaoje YS. Prediabetes deserves more attention: a review. Clin Diabetes. 2020;38:328–338. doi: 10.2337/cd19-0101CrossrefPubMedGoogle Scholar3.Wasserman DH, Wang TJ, Brown NJ. The vasculature in prediabetes. Circ Res. 2018;122:1135–1150. doi: 10.1161/CIRCRESAHA.118.311912CrossrefPubMedGoogle Scholar4.Vincent MA, Clerk LH, Rattigan S, Clark MG, Barrett EJ. Active role for the vasculature in the delivery of insulin to skeletal muscle. Clin Exp Pharmacol Physiol. 2005;32:302–307. doi: 10.1111/j.1440-1681.2005.04188.xCrossrefPubMedGoogle Scholar5.White MF, Kahn CR. The insulin signaling system. J Biol Chem. 1994;269:1–4.CrossrefPubMedGoogle Scholar6.Long YC, Zierath JR. Influence of AMP-activated protein kinase and calcineurin on metabolic networks in skeletal muscle. Am J Physiol Endocrinol Metab. 2008;295:E545–E552. doi: 10.1152/ajpendo.90259.2008CrossrefPubMedGoogle Scholar7.DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214–E223. doi: 10.1152/ajpendo.1979.237.3.E214CrossrefPubMedGoogle Scholar8.DeFronzo RA, Ferrannini E, Hendler R, Felig P, Wahren J. Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes. 1983;32:35–45. doi: 10.2337/diab.32.1.35CrossrefPubMedGoogle Scholar9.Dawson D, Vincent MA, Barrett EJ, Kaul S, Clark A, Leong-Poi H, Lindner JR. Vascular recruitment in skeletal muscle during exercise and hyperinsulinemia assessed by contrast ultrasound. Am J Physiol Endocrinol Metab. 2002;282:E714–E720. doi: 10.1152/ajpendo.00373.2001CrossrefPubMedGoogle Scholar10.DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes. 1981;30:1000–1007. doi: 10.2337/diab.30.12.1000CrossrefPubMedGoogle Scholar11.Yang YJ, Hope ID, Ader M, Bergman RN. Insulin transport across capillaries is rate limiting for insulin action in dogs. J Clin Invest. 1989;84:1620–1628. doi: 10.1172/JCI114339CrossrefPubMedGoogle Scholar12.Yang YJ, Hope ID, Ader M, Bergman RN. Importance of transcapillary insulin transport to dynamics of insulin action after intravenous glucose. Am J Physiol. 1994;266:E17–E25. doi: 10.1152/ajpendo.1994.266.1.E17CrossrefPubMedGoogle Scholar13.Kolka CM, Bergman RN. The barrier within: endothelial transport of hormones. Physiology (Bethesda). 2012;27:237–247. doi: 10.1152/physiol.00012.2012CrossrefPubMedGoogle Scholar14.Kubota T, Kubota N, Kumagai H, Yamaguchi S, Kozono H, Takahashi T, Inoue M, Itoh S, Takamoto I, Sasako T, et al. Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle. Cell Metab. 2011;13:294–307. doi: 10.1016/j.cmet.2011.01.018CrossrefPubMedGoogle Scholar15.Sjostrand M, Holmang A, Lonnroth P. Measurement of interstitial insulin in human muscle. Am J Physiol. 1999;276:E151–E154. doi: 10.1152/ajpendo.1999.276.1.E151CrossrefPubMedGoogle Scholar16.Sjostrand M, Holmang A, Strindberg L, Lonnroth P. Estimations of muscle interstitial insulin, glucose, and lactate in type 2 diabetic subjects. Am J Physiol Endocrinol Metab. 2000;279:E1097–E1103. doi: 10.1152/ajpendo.2000.279.5.E1097CrossrefPubMedGoogle Scholar17.McClatchey PM, Williams IM, Xu Z, Mignemi NA, Hughey CC, McGuinness OP, Beckman JA, Wasserman DH. Perfusion controls muscle glucose uptake by altering the rate of glucose dispersion in vivo. Am J Physiol Endocrinol Metab. 2019;317:E1022–E1036. doi: 10.1152/ajpendo.00260.2019CrossrefPubMedGoogle Scholar18.Akerstrom T, Goldman D, Nilsson F, Milkovich SL, Fraser GM, Brand CL, Hellsten Y, Ellis CG. Hyperinsulinemia does not cause de novo capillary recruitment in rat skeletal muscle. Microcirculation. 2020;27:e12593. doi: 10.1111/micc.12593CrossrefPubMedGoogle Scholar19.Williams IM, McClatchey PM, Bracy DP, Bonner JS, Valenzuela FA, Wasserman DH. Transendothelial insulin transport is impaired in skeletal muscle capillaries of obese male mice. Obesity (Silver Spring). 2020;28:303–314. doi: 10.1002/oby.22683CrossrefPubMedGoogle Scholar20.Williams IM, Valenzuela FA, Kahl SD, Ramkrishna D, Mezo AR, Young JD, Wells KS, Wasserman DH. Insulin exits skeletal muscle capillaries by fluid-phase transport. J Clin Invest. 2018;128:699–714. doi: 10.1172/JCI94053CrossrefPubMedGoogle Scholar21.Broussard JL, Castro AV, Iyer M, Paszkiewicz RL, Bediako IA, Szczepaniak LS, Szczepaniak EW, Bergman RN, Kolka CM. Insulin access to skeletal muscle is impaired during the early stages of diet-induced obesity. Obesity (Silver Spring). 2016;24:1922–1928. doi: 10.1002/oby.21562CrossrefPubMedGoogle Scholar22.Kolka CM, Bergman RN. The endothelium in diabetes: its role in insulin access and diabetic complications. Rev Endocr Metab Disord. 2013;14:13–19. doi: 10.1007/s11154-012-9233-5CrossrefPubMedGoogle Scholar23.Kolka CM, Harrison LN, Lottati M, Chiu JD, Kirkman EL, Bergman RN. Diet-induced obesity prevents interstitial dispersion of insulin in skeletal muscle. Diabetes. 2010;59:619–626. doi: 10.2337/db09-0839CrossrefPubMedGoogle Scholar24.Lee WL, Klip A. Endothelial transcytosis of insulin: Does it contribute to insulin resistance? Physiology (Bethesda). 2016;31:336–345. doi: 10.1152/physiol.00010.2016CrossrefPubMedGoogle Scholar25.Sherwin RS, Kramer KJ, Tobin JD, Insel PA, Liljenquist JE, Berman M, Andres R. A model of the kinetics of insulin in man. J Clin Invest. 1974;53:1481–1492. doi: 10.1172/JCI107697CrossrefPubMedGoogle Scholar26.Chiu JD, Richey JM, Harrison LN, Zuniga E, Kolka CM, Kirkman E, Ellmerer M, Bergman RN. Direct administration of insulin into skeletal muscle reveals that the transport of insulin across the capillary endothelium limits the time course of insulin to activate glucose disposal. Diabetes. 2008;57:828–835. doi: 10.2337/db07-1444CrossrefPubMedGoogle Scholar27.Prager R, Wallace P, Olefsky JM. In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. J Clin Invest. 1986;78:472–481. doi: 10.1172/JCI112599CrossrefPubMedGoogle Scholar28.Turk D, Alzaid A, Dinneen S, Nair KS, Rizza R. The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues. J Clin Invest. 1995;95:755–762. doi: 10.1172/JCI117723CrossrefPubMedGoogle Scholar29.Sjostrand M, Gudbjornsdottir S, Holmang A, Lonn L, Strindberg L, Lonnroth P. Delayed transcapillary transport of insulin to muscle interstitial fluid in obese subjects. Diabetes. 2002;51:2742–2748. doi: 10.2337/diabetes.51.9.2742CrossrefPubMedGoogle Scholar30.Sandqvist M, Strindberg L, Schmelz M, Lonnroth P, Jansson PA. Impaired delivery of insulin to adipose tissue and skeletal muscle in obese women with postprandial hyperglycemia. J Clin Endocrinol Metab. 2011;96:E1320–E1324. doi: 10.1210/jc.2011-0233CrossrefPubMedGoogle Scholar31.Barrett EJ, Wang H, Upchurch CT, Liu Z. Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature. Am J Physiol Endocrinol Metab. 2011;301:E252–E263. doi: 10.1152/ajpendo.00186.2011CrossrefPubMedGoogle Scholar32.Kubota T, Kubota N, Kadowaki T. The role of endothelial insulin signaling in the regulation of glucose metabolism. Rev Endocr Metab Disord. 2013;14:207–216. doi: 10.1007/s11154-013-9242-zCrossrefPubMedGoogle Scholar33.Williams IM, Wasserman DH. Capillary endothelial insulin transport: the rate-limiting step for insulin-stimulated glucose uptake. Endocrinology. 2022;163:bqab252. doi: 10.1210/endocr/bqab252CrossrefPubMedGoogle Scholar34.Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest. 1990;85:1844–1852. doi: 10.1172/JCI114644CrossrefPubMedGoogle Scholar35.Laakso M, Edelman SV, Brechtel G, Baron AD. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes. 1992;41:1076–1083. doi: 10.2337/diab.41.9.1076CrossrefPubMedGoogle Scholar36.Duplain H, Burcelin R, Sartori C, Cook S, Egli M, Lepori M, Vollenweider P, Pedrazzini T, Nicod P, Thorens B, et al. Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation. 2001;104:342–345. doi: 10.1161/01.cir.104.3.342CrossrefPubMedGoogle Scholar37.Wallis MG, Wheatley CM, Rattigan S, Barrett EJ, Clark AD, Clark MG. Insulin-mediated hemodynamic changes are impaired in muscle of Zucker obese rats. Diabetes. 2002;51:3492–3498. doi: 10.2337/diabetes.51.12.3492CrossrefPubMedGoogle Scholar38.Halseth AE, Bracy DP, Wasserman DH. Limitations to basal and insulin-stimulated skeletal muscle glucose uptake in the high-fat-fed rat. Am J Physiol Endocrinol Metab. 2000;279:E1064–E1071. doi: 10.1152/ajpendo.2000.279.5.E1064CrossrefPubMedGoogle Scholar39.Clark MG. Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle. Am J Physiol Endocrinol Metab. 2008;295:E732–E750. doi: 10.1152/ajpendo.90477.2008CrossrefPubMedGoogle Scholar40.Barrett EJ, Eggleston EM, Inyard AC, Wang H, Li G, Chai W, Liu Z. The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action. Diabetologia. 2009;52:752–764. doi: 10.1007/s00125-009-1313-zCrossrefPubMedGoogle Scholar41.Vincent MA, Dawson D, Clark AD, Lindner JR, Rattigan S, Clark MG, Barrett EJ. Skeletal muscle microvascular recruitment by physiological hyperinsulinemia precedes increases in total blood flow. Diabetes. 2002;51:42–48. doi: 10.2337/diabetes.51.1.42CrossrefPubMedGoogle Scholar42.Miles PD, Levisetti M, Reichart D, Khoursheed M, Moossa AR, Olefsky JM. Kinetics of insulin action in vivo. Identification of rate-limiting steps. Diabetes. 1995;44:947–953. doi: 10.2337/diab.44.8.947CrossrefPubMedGoogle Scholar43.Oezdemir I, Peng J, Ghosh D, Sirsi S, Mineo C, Shaul PW, Hoyt K. Multiscale and morphological analysis of microvascular patterns depicted in contrast-enhanced ultrasound images. J Med Imaging (Bellingham). 2020;7:034001. doi: 10.1117/1.JMI.7.3.034001CrossrefPubMedGoogle Scholar44.Aird WC. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res. 2007;100:174–190. doi: 10.1161/01.RES.0000255690.03436.aeCrossrefPubMedGoogle Scholar45.Aird WC. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res. 2007;100:158–173. doi: 10.1161/01.RES.0000255691.76142.4aCrossrefPubMedGoogle Scholar46.Azizi PM, Zyla RE, Guan S, Wang C, Liu J, Bolz SS, Heit B, Klip A, Lee WL. Clathrin-dependent entry and vesicle-mediated exocytosis define insulin transcytosis across microvascular endothelial cells. Mol Biol Cell. 2015;26:740–750. doi: 10.1091/mbc.E14-08-1307CrossrefPubMedGoogle Scholar47.Fung KYY, Fairn GD, Lee WL. Transcellular vesicular transport in epithelial and endothelial cells: challenges and opportunities. Traffic. 2018;19:5–18. doi: 10.1111/tra.12533CrossrefPubMedGoogle Scholar48.Sanwal R, Khosraviani N, Advani SL, Advani A, Lee WL. The endothelial barrier is not rate-limiting to insulin action in the myocardium of male mice. Endocrinology. 2020;161:bqaa029. doi: 10.1210/endocr/bqaa029CrossrefPubMedGoogle Scholar49.Yazdani S, Jaldin-Fincati JR, Pereira RVS, Klip A. Endothelial cell barriers: transport of molecules between blood and tissues. Traffic. 2019;20:390–403. doi: 10.1111/tra.12645CrossrefPubMedGoogle Scholar50.King GL, Johnson SM. Receptor-mediated transport of insulin across endothelial cells. Science. 1985;227:1583–1586. doi: 10.1126/science.3883490CrossrefPubMedGoogle Scholar51.Dernovsek KD, Bar RS. Processing of cell-bound insulin by capillary and macrovascular endothelial cells in culture. Am J Physiol. 1985;248:E244–E251. doi: 10.1152/ajpendo.1985.248.2.E244CrossrefPubMedGoogle Scholar52.Schnitzer JE, Oh P, Pinney E, Allard J. Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J Cell Biol. 1994;127:1217–1232. doi: 10.1083/jcb.127.5.1217CrossrefPubMedGoogle Scholar53.Wang H, Liu Z, Li G, Barrett EJ. The vascular endothelial cell mediates insulin transport into skeletal muscle. Am J Physiol Endocrinol Metab. 2006;291:E323–E332. doi: 10.1152/ajpendo.00047.2006CrossrefPubMedGoogle Scholar54.Li G, Barrett EJ, Wang H, Chai W, Liu Z. Insulin at physiological concentrations selectively activates insulin but not insulin-like growth factor I (IGF-I) or insulin/IGF-I hybrid receptors in endothelial cells. Endocrinology. 2005;146:4690–4696. doi: 10.1210/en.2005-0505CrossrefPubMedGoogle Scholar55.Yu Y, Kastin AJ, Pan W. Reciprocal interactions of insulin and insulin-like growth factor I in receptor-mediated transport across the blood-brain barrier. Endocrinology. 2006;147:2611–2615. doi: 10.1210/en.2006-0020CrossrefPubMedGoogle Scholar56.Majumdar S, Genders AJ, Inyard AC, Frison V, Barrett EJ. Insulin entry into muscle involves a saturable process in the vascular endothelium. Diabetologia. 2012;55:450–456. doi: 10.1007/s00125-011-2343-xCrossrefPubMedGoogle Scholar57.Steil GM, Ader M, Moore DM, Rebrin K, Bergman RN. Transendothelial insulin transport is not saturable in vivo. No evidence for a receptor-mediated process. J Clin Invest. 1996;97:1497–1503. doi: 10.1172/JCI118572CrossrefPubMedGoogle Scholar58.Hamilton-Wessler M, Ader M, Dea MK, Moore D, Loftager M, Markussen J, Bergman RN. Mode of transcapillary transport of insulin and insulin analog NN304 in dog hindlimb: evidence for passive diffusion. Diabetes. 2002;51:574–582. doi: 10.2337/diabetes.51.3.574CrossrefPubMedGoogle Scholar59.Konishi M, Sakaguchi M, Lockhart SM, Cai W, Li ME, Homan EP, Rask-Madsen C, Kahn CR. Endothelial insulin receptors differentially control insulin signaling kinetics in peripheral tissues and brain of mice. Proc Natl Acad Sci USA. 2017;114:E8478–E8487. doi: 10.1073/pnas.1710625114CrossrefPubMedGoogle Scholar60.Cogger VC, McNerney GP, Nyunt T, DeLeve LD, McCourt P, Smedsrod B, Le Couteur DG, Huser TR. Three-dimensional structured illumination microscopy of liver sinusoidal endothelial cell fenestrations. J Struct Biol. 2010;171:382–388. doi: 10.1016/j.jsb.2010.06.001CrossrefPubMedGoogle Scholar61.Duckworth WC, Bennett RG, Hamel FG. Insulin degradation: progress and potential. Endocr Rev. 1998;19:608–624. doi: 10.1210/edrv.19.5.0349CrossrefPubMedGoogle Scholar62.Wang H, Wang AX, Liu Z, Barrett EJ. Insulin signaling stimulates insulin transport by bovine aortic endothelial cells. Diabetes. 2008;57:540–547. doi: 10.2337/db07-0967CrossrefPubMedGoogle Scholar63.Wang H, Wang AX, Barrett EJ. Insulin-induced endothelial cell cortical actin filament remodeling: a requirement for trans-endothelial insulin transport. Mol Endocrinol. 2012;26:1327–1338. doi: 10.1210/me.2012-1003CrossrefPubMedGoogle Scholar64.Muniyappa R, Montagnani M, Koh KK, Quon MJ. Cardiovascular actions of insulin. Endocr Rev. 2007;28:463–491. doi: 10.1210/er.2007-0006CrossrefPubMedGoogle Scholar65.Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 1999;399:601–605. doi: 10.1038/21224CrossrefPubMedGoogle Scholar66.Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest. 1996;98:894–898. doi: 10.1172/JCI118871CrossrefPubMedGoogle Scholar67.Zeng G, Nystrom FH, Ravichandran LV, Cong LN, Kirby M, Mostowski H, Quon MJ. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation. 2000;101:1539–1545. doi: 10.1161/01.cir.101.13.1539CrossrefPubMedGoogle Scholar68.Montagnani M, Golovchenko I, Kim I, Koh GY, Goalstone ML, Mundhekar AN, Johansen M, Kucik DF, Quon MJ, Draznin B. Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. J Biol Chem. 2002;277:1794–1799. doi: 10.1074/jbc.M103728200CrossrefPubMedGoogle Scholar69.Cardillo C, Nambi SS, Kilcoyne CM, Choucair WK, Katz A, Quon MJ, Panza JA. Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation. 1999;100:820–825. doi: 10.1161/01.cir.100.8.820CrossrefPubMedGoogle Scholar70.Vincent MA, Barrett EJ, Lindner JR, Clark MG, Rattigan S. Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am J Physiol Endocrinol Metab. 2003;285:E123–E129. doi: 10.1152/ajpendo.00021.2003CrossrefPubMedGoogle Scholar71.Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin’s vascular effects in humans. J Clin Invest. 1994;94:2511–2515. doi: 10.1172/JCI117621CrossrefPubMedGoogle Scholar72.Kainoh M, Maruyama I, Nishio S, Nakadate T. Enhancement by beraprost sodium, a stable analogue of prostacyclin, in thrombomodulin expression on membrane surface of cultured vascular endothelial cells via increase in cyclic AMP level. Biochem Pharmacol. 1991;41:1135–1140. doi: 10.1016/0006-2952(91)90651-kCrossrefPubMedGoogle Scholar73.Niwano K, Arai M, Tomaru K, Uchiyama T, Ohyama Y, Kurabayashi M. Transcriptional stimulation of the eNOS gene by the stable prostacyclin analogue beraprost is mediated through cAMP-responsive element in vascular endothelial cells: close link between PGI2 signal and NO pathways. Circ Res. 2003;93:523–530. doi: 10.1161/01.RES.0000091336.55487.F7CrossrefPubMedGoogle Scholar74.Lievre M, Morand S, Besse B, Fiessinger JN, Boissel JP. Oral Beraprost sodium, a prostaglandin I(2) analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial. Beraprost et Claudication Intermittente (BERCI) Research Group. Circulation. 2000;102:426–431. doi: 10.1161/01.cir.102.4.426CrossrefPubMedGoogle Scholar75.Galie N, Humbert M, Vachiery JL, Vizza CD, Kneussl M, Manes A, Sitbon O, Torbicki A, Delcroix M, Naeije R, et al; Arterial Pulmonary Hypertension and Beraprost European (ALPHABET) Study Group. Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol. 2002;39:1496–1502. doi: 10.1016/s0735-1097(02)01786-2CrossrefPubMedGoogle Scholar76.Ayala JE, Bracy DP, Julien BM, Rottman JN, Fueger PT, Wasserman DH. Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice. Diabetes. 2007;56:1025–1033. doi: 10.2337/db06-0883CrossrefPubMedGoogle Scholar77.Chai W, Fu Z, Aylor KW, Barrett EJ, Liu Z. Liraglutide prevents microvascular insulin resistance and preserves muscle capillary density in high-fat diet-fed rats. Am J Physiol Endocrinol Metab. 2016;311:E640–E648. doi: 10.1152/ajpendo.00205.2016CrossrefPubMedGoogle Scholar78.Bonner JS, Lantier L, Hocking KM, Kang L, Owolabi M, James FD, Bracy DP, Brophy CM, Wasserman DH. Relaxin treatment reverses insulin resistance in mice fed a high-fat diet. Diabetes. 2013;62:3251–3260. doi: 10.2337/db13-0033CrossrefPubMedGoogle Scholar79.Baron AD, Tarshoby M, Hook G, Lazaridis EN, Cronin J, Johnson A, Steinberg HO. Interaction between insulin sensitivity and muscle perfusion on glucose uptake in human skeletal muscle: evidence for capillary recruitment. Diabetes. 2000;49:768–774. doi: 10.2337/diabetes.49.5.768CrossrefPubMedGoogle Scholar80.Jansson PA, Murdolo G, Sjogren L, Nystrom B, Sjostrand M, Strindberg L, Lonnroth P. Tadalafil increases muscle capillary recruitment and forearm glucose uptake in women with type 2 diabetes. Diabetologia. 2010;53:2205–2208. doi: 10.1007/s00125-010-1819-4CrossrefPubMedGoogle Scholar81.Wang H, Wang AX, Aylor K, Barrett EJ. Nitric oxide directly promotes vascular endothelial insulin transport. Diabetes. 2013;62:4030–4042. doi: 10.2337/db13-0627CrossrefPubMedGoogle Scholar82.Mauvais-Jarvis F, Clegg DJ, Hevener AL. The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev. 2013;34:309–338. doi: 10.1210/er.2012-1055CrossrefPubMedGoogle Scholar83.Hevener AL, Clegg DJ, Mauvais-Jarvis F. Impaired estrogen receptor action in the pathogenesis of the metabolic syndrome. Mol Cell Endocrinol. 2015;418 Pt 3:306–321. doi: 10.1016/j.mce.2015.05.020CrossrefPubMedGoogle Scholar84.Wagner JD, Thomas MJ, Williams JK, Zhang L, Greaves KA, Cefalu WT. Insulin sensitivity and cardiovascular risk factors in ovariectomized monkeys with estradiol alone or combined with nomegestrol acetate. J Clin Endocrinol Metab. 1998;83:896–901. doi: 10.1210/jcem.83.3.4628CrossrefPubMedGoogle Scholar85.Kumagai S, Holmang A, Bjorntorp P. The effects of oestrogen and progesterone on insulin sensitivity in female rats. Acta Physiol Scand. 1993;149:91–97. doi: 10.1111/j.1748-1716.1993.tb09596.xCrossrefPubMedGoogle Scholar86.Riant E, Waget A, Cogo H, Arnal JF, Burcelin R, Gourdy P. Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology. 2009;150:2109–2117. doi: 10.1210/en.2008-0971CrossrefPubMedGoogle Scholar87.Osborne CK, Schiff R. Estrogen-receptor biology: continuing progress and therapeutic implications. J Clin Oncol. 2005;23:1616–1622. doi: 10.1200/JCO.2005.10.036CrossrefPubMedGoogle Scholar88.Musatov S, Chen W, Pfaff DW, Mobbs CV, Yang XJ, Clegg DJ, Kaplitt MG, Ogawa S. Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proc Natl Acad Sci USA. 2007;104:2501–2506. doi: 10.1073/pnas.0610787104CrossrefPubMedGoogle Scholar89.Bryzgalova G, Lundholm L, Portwood N, Gustafsson JA, Khan A, Efendic S, Dahlman-Wright K. Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice. Am J Physiol Endocrinol Metab. 2008;295:E904–E912. doi: 10.1152/ajpendo.90248.2008CrossrefPubMedGoogle Scholar90.Ropero AB, Alonso-Magdalena P, Quesada I, Nadal A. The role of estrogen receptors in the control of energy and glucose homeostasis. Steroids. 2008;73:874–879. doi: 10.1016/j.steroids.2007.12.018CrossrefPubMedGoogle Scholar91.Barros R, Gabbi C, Morani A, Warner M, Gustafsson JA. Participation of ER{alpha} and ER{beta} in glucose homeostasis in skeletal muscle and white adipose tissue. Am J Physiol Endocrinol Metab. 2009;297:E124. doi: 10.1152/ajpendo.00189.2009CrossrefPubMedGoogle Scholar92.Davis KE, Neinast D, Sun K, Skiles M, Bills D, Zehr A, Zeve D, Hahner D, Cox W, Gent M, et al. The sexually dimorphic role of adipose and adipocyte estrogen receptors in modulating adipose tissue expansion, inflammation, and fibrosis. Mol Metab. 2013;2:227–242. doi: 10.1016/j.molmet.2013.05.006CrossrefPubMedGoogle Scholar93.Ribas V, Drew BG, Le JA, Soleymani T, Daraei P, Sitz D, Mohammad L, Henstridge DC, Febbraio MA, Hewitt SC, et al. Myeloid-specific estrogen receptor {alpha} deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development. Proc Natl Acad Sci USA. 2011;108:16457–16462. doi: 10.1073/pnas.1104533108CrossrefPubMedGoogle Scholar94.Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci USA. 2000;97:12729–12734. doi: 10.1073/pnas.97.23.12729CrossrefPubMedGoogle Scholar95.Bryzgalova G, Gao H, Ahren B, Zierath JR, Galuska D, Steiler TL, Dahlman-Wright K, Nilsson S, Gustafsson JA, Efendic S, et al. Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia. 2006;49:588–597. doi: 10.1007/s00125-005-0105-3CrossrefPubMedGoogle Scholar96.Heianza Y, Arase Y, Kodama S, Hsieh SD, Tsuji H, Saito K, Shimano H, Hara S, Sone H. Effect of postmenopausal status and age at menopause on type 2 diabetes and prediabetes in Japanese individuals: Toranomon Hospital Health Management Center Study 17 (TOPICS 17). Diabetes Care. 2013;36:4007–4014. doi: 10.2337/dc13-1048CrossrefPubMedGoogle Scholar97.Gurka MJ, Vishnu A, Santen RJ, DeBoer MD. Progression of metabolic syndrome severity during the menopausal transition. J Am Heart Assoc. 2016;5:e003609. doi: 10.1161/JAHA.116.003609CrossrefPubMedGoogle Scholar98.Szmuilowicz ED, Stuenkel CA, Seely EW. Influence of menopause on diabetes and diabetes risk. Nat Rev Endocrinol. 2009;5:553–558. doi: 10.1038/nrendo.2009.166CrossrefPubMedGoogle Scholar99.Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 1994;331:1056–1061. doi: 10.1056/NEJM199410203311604CrossrefPubMedGoogle Scholar100.Maffei L, Murata Y, Rochira V, Tubert G, Aranda C, Vazquez M, Clyne CD, Davis S, Simpson ER, Carani C. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab. 2004;89:61–70. doi: 10.1210/jc.2003-030313CrossrefPubMedGoogle Scholar101.Rochira V, Madeo B, Zirilli L, Caffagni G, Maffei L, Carani C. Oestradiol replacement treatment and glucose homeostasis in two men with congenital aromatase deficiency: evidence for a role of oestradiol and sex steroids imbalance on insulin sensitivity in men. Diabet Med. 2007;24:1491–1495. doi: 10.1111/j.1464-5491.2007.02304.xCrossrefPubMedGoogle Scholar102.Takeda K, Toda K, Saibara T, Nakagawa M, Saika K, Onishi T, Sugiura T, Shizuta Y. Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J Endocrinol. 2003;176:237–246. doi: 10.1677/joe.0.1760237CrossrefPubMedGoogle Scholar103.Chambliss KL, Shaul PW. Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev. 2002;23:665–686. doi: 10.1210/er.2001-0045CrossrefPubMedGoogle Scholar104.Levin ER. Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol. 2005;19:1951–1959. doi: 10.1210/me.2004-0390CrossrefPubMedGoogle Scholar105.Lantin-Hermoso RL, Rosenfeld CR, Yuhanna IS, German Z, Chen Z, Shaul PW. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am J Physiol. 1997;273:L119–L126. doi: 10.1152/ajplung.1997.273.1.L119CrossrefPubMedGoogle Scholar106.Chambliss KL, Yuhanna IS, Mineo C, Liu P, German Z, Sherman TS, Mendelsohn ME, Anderson RG, Shaul PW. Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circ Res. 2000;87:E44–E52. doi: 10.1161/01.res.87.11.e44CrossrefPubMedGoogle Scholar107.Sacharidou A, Chambliss K, Peng J, Barrera J, Tanigaki K, Luby-Phelps K, Ozdemir I, Khan S, Sirsi SR, Kim SH, et al. Endothelial ERalpha promotes glucose tolerance by enhancing endothelial insulin transport to skeletal muscle. Nat Commun. 2023;14:4989. doi: 10.1038/s41467-023-40562-wCrossrefPubMedGoogle Scholar108.Gu P, Xu A. Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction. Rev Endocr Metab Disord. 2013;14:49–58. doi: 10.1007/s11154-012-9230-8CrossrefPubMedGoogle Scholar109.Scalia R. The microcirculation in adipose tissue inflammation. Rev Endocr Metab Disord. 2013;14:69–76. doi: 10.1007/s11154-013-9236-xCrossrefPubMedGoogle Scholar110.Chambliss KL, Wu Q, Oltmann S, Konaniah ES, Umetani M, Korach KS, Thomas GD, Mineo C, Yuhanna IS, Kim SH, et al. Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J Clin Invest. 2010;120:2319–2330. doi: 10.1172/JCI38291CrossrefPubMedGoogle Scholar111.Lu Q, Schnitzler GR, Ueda K, Iyer LK, Diomede OI, Andrade T, Karas RH. ER alpha rapid signaling is required for estrogen induced proliferation and migration of vascular endothelial cells. PLoS One. 2016;11:e0152807. doi: 10.1371/journal.pone.0152807CrossrefPubMedGoogle Scholar112.Nilsson BO. Modulation of the inflammatory response by estrogens with focus on the endothelium and its interactions with leukocytes. Inflamm Res. 2007;56:269–273. doi: 10.1007/s00011-007-6198-zCrossrefPubMedGoogle Scholar113.Teasdale RD, Loci D, Houghton F, Karlsson L, Gleeson PA. A large family of endosome-localized proteins related to sorting nexin 1. Biochem J. 2001;358:7–16. doi: 10.1042/0264-6021:3580007CrossrefGoogle Scholar114.Worby CA, Dixon JE. Sorting out the cellular functions of sorting nexins. Nat Rev Mol Cell Biol. 2002;3:919–931. doi: 10.1038/nrm974CrossrefPubMedGoogle Scholar115.Haft CR, de la Luz SM, Barr VA, Haft DH, Taylor SI. Identification of a family of sorting nexin molecules and characterization of their association with receptors. Mol Cell Biol. 1998;18:7278–7287. doi: 10.1128/mcb.18.12.7278CrossrefPubMedGoogle Scholar116.Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881–887. doi: 10.1038/nature05488CrossrefPubMedGoogle Scholar117.Rabinowitz D, Zierler KL. Forearm metabolism in obesity and its response to intra-arterial insulin. Characterization of insulin resistance and evidence for adaptive hyperinsulinism. J Clin Invest. 1962;41:2173–2181. doi: 10.1172/JCI104676CrossrefPubMedGoogle Scholar118.DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care. 2009;32:S157–S163. doi: 10.2337/dc09-S302CrossrefPubMedGoogle Scholar119.Gudbjornsdottir S, Sjostrand M, Strindberg L, Wahren J, Lonnroth P. Direct measurements of the permeability surface area for insulin and glucose in human skeletal muscle. J Clin Endocrinol Metab. 2003;88:4559–4564. doi: 10.1210/jc.2003-030434CrossrefPubMedGoogle Scholar120.Bergman RN. Insulin action and distribution of tissue blood flow. J Clin Endocrinol Metab. 2003;88:4556–4558. doi: 10.1210/jc.2003-031431CrossrefPubMedGoogle Scholar121.Pillon NJ, Azizi PM, Li YE, Liu J, Wang C, Chan KL, Hopperton KE, Bazinet RP, Heit B, Bilan PJ, et al. Palmitate-induced inflammatory pathways in human adipose microvascular endothelial cells promote monocyte adhesion and impair insulin transcytosis. Am J Physiol Endocrinol Metab. 2015;309:E35–E44. doi: 10.1152/ajpendo.00611.2014CrossrefPubMedGoogle Scholar122.Winer DA, Winer S, Shen L, Wadia PP, Yantha J, Paltser G, Tsui H, Wu P, Davidson MG, Alonso MN, et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med. 2011;17:610–617. doi: 10.1038/nm.2353CrossrefPubMedGoogle Scholar123.Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017;127:1–4. doi: 10.1172/JCI92035CrossrefPubMedGoogle Scholar124.Tanigaki K, Vongpatanasin W, Barrera JA, Atochin DN, Huang PL, Bonvini E, Shaul PW, Mineo C. C-reactive protein causes insulin resistance in mice through Fcgamma receptor IIB-mediated inhibition of skeletal muscle glucose delivery. Diabetes. 2013;62:721–731. doi: 10.2337/db12-0133CrossrefPubMedGoogle Scholar125.Tanigaki K, Chambliss KL, Yuhanna IS, Sacharidou A, Ahmed M, Atochin DN, Huang PL, Shaul PW, Mineo C. Endothelial Fcgamma receptor IIB activation blunts insulin delivery to skeletal muscle to cause insulin resistance in mice. Diabetes. 2016;65:1996–2005. doi: 10.2337/db15-1605CrossrefPubMedGoogle Scholar126.Ferrara C, Grau S, Jager C, Sondermann P, Brunker P, Waldhauer I, Hennig M, Ruf A, Rufer AC, Stihle M, et al. Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose. Proc Natl Acad Sci USA. 2011;108:12669–12674. doi: 10.1073/pnas.1108455108CrossrefPubMedGoogle Scholar127.Anthony RM, Wermeling F, Ravetch JV. Novel roles for the IgG Fc glycan. Ann N Y Acad Sci. 2012;1253:170–180. doi: 10.1111/j.1749-6632.2011.06305.xCrossrefPubMedGoogle Scholar128.Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol. 2008;8:34–47. doi: 10.1038/nri2206CrossrefPubMedGoogle Scholar129.Damelang T, Brinkhaus M, van Osch TLJ, Schuurman J, Labrijn AF, Rispens T, Vidarsson G. Impact of structural modifications of IgG antibodies on effector functions. Front Immunol. 2023;14:1304365. doi: 10.3389/fimmu.2023.1304365CrossrefPubMedGoogle Scholar130.Kristic J, Lauc G. The importance of IgG glycosylation-what did we learn after analyzing over 100,000 individuals. Immunol Rev. 2024;328:143–170. doi: 10.1111/imr.13407CrossrefPubMedGoogle Scholar131.Gudelj I, Lauc G, Pezer M. Immunoglobulin G glycosylation in aging and diseases. Cell Immunol. 2018;333:65–79. doi: 10.1016/j.cellimm.2018.07.009CrossrefPubMedGoogle Scholar132.Vattepu R, Sneed SL, Anthony RM. Sialylation as an important regulator of antibody function. Front Immunol. 2022;13:818736. doi: 10.3389/fimmu.2022.818736CrossrefPubMedGoogle Scholar133.Nikolac Perkovic M, Pucic Bakovic M, Kristic J, Novokmet M, Huffman JE, Vitart V, Hayward C, Rudan I, Wilson JF, Campbell H, et al. The association between galactosylation of immunoglobulin G and body mass index. Prog Neuropsychopharmacol Biol Psychiatry. 2014;48:20–25. doi: 10.1016/j.pnpbp.2013.08.014CrossrefPubMedGoogle Scholar134.Russell AC, Kepka A, Trbojevic-Akmacic I, Ugrina I, Song M, Hui J, Hunter M, Laws SM, Lauc G, Wang W. Increased central adiposity is associated with pro-inflammatory immunoglobulin G N-glycans. Immunobiology. 2019;224:110–115. doi: 10.1016/j.imbio.2018.10.002CrossrefPubMedGoogle Scholar135.Liu D, Li Q, Dong J, Li D, Xu X, Xing W, Zhang X, Cao W, Hou H, Wang H, et al. The association between normal BMI with central adiposity and proinflammatory potential immunoglobulin G N-glycosylation. Diabetes Metab Syndr Obes. 2019;12:2373–2385. doi: 10.2147/DMSO.S216318CrossrefPubMedGoogle Scholar136.Tanigaki K, Sacharidou A, Peng J, Chambliss KL, Yuhanna IS, Ghosh D, Ahmed M, Szalai AJ, Vongpatanasin W, Mattrey RF, et al. Hyposialylated IgG activates endothelial IgG receptor FcgammaRIIB to promote obesity-induced insulin resistance. J Clin Invest. 2018;128:309–322. doi: 10.1172/JCI89333CrossrefPubMedGoogle Scholar137.Solar P, Zamani A, Lakatosova K, Joukal M. The blood-brain barrier and the neurovascular unit in subarachnoid hemorrhage: molecular events and potential treatments. Fluids Barriers CNS. 2022;19:29. doi: 10.1186/s12987-022-00312-4CrossrefPubMedGoogle Scholar138.Engelhardt B, Sorokin L. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin Immunopathol. 2009;31:497–511. doi: 10.1007/s00281-009-0177-0CrossrefPubMedGoogle Scholar139.Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis. 2010;37:13–25. doi: 10.1016/j.nbd.2009.07.030CrossrefPubMedGoogle Scholar140.Bernacki J, Dobrowolska A, Nierwinska K, Malecki A. Physiology and pharmacological role of the blood-brain barrier. Pharmacol Rep. 2008;60:600–622.PubMedGoogle Scholar141.Andreone BJ, Chow BW, Tata A, Lacoste B, Ben-Zvi A, Bullock K, Deik AA, Ginty DD, Clish CB, Gu C. Blood-brain barrier permeability is regulated by lipid transport-dependent suppression of caveolae-mediated transcytosis. Neuron. 2017;94:581–594.e5. doi: 10.1016/j.neuron.2017.03.043CrossrefPubMedGoogle Scholar142.Ohtsuki S. Insulin receptor at the blood-brain barrier: transport and signaling. Vitam Horm. 2024;126:113–124. doi: 10.1016/bs.vh.2024.05.001CrossrefPubMedGoogle Scholar143.Pomytkin I, Costa-Nunes JP, Kasatkin V, Veniaminova E, Demchenko A, Lyundup A, Lesch KP, Ponomarev ED, Strekalova T. Insulin receptor in the brain: mechanisms of activation and the role in the CNS pathology and treatment. CNS Neurosci Ther. 2018;24:763–774. doi: 10.1111/cns.12866CrossrefPubMedGoogle Scholar144.Rhea EM, Rask-Madsen C, Banks WA. Insulin transport across the blood-brain barrier can occur independently of the insulin receptor. J Physiol. 2018;596:4753–4765. doi: 10.1113/JP276149CrossrefPubMedGoogle Scholar145.Akhtar A, Sah SP. Insulin signaling pathway and related molecules: role in neurodegeneration and Alzheimer’s disease. Neurochem Int. 2020;135:104707. doi: 10.1016/j.neuint.2020.104707CrossrefPubMedGoogle Scholar146.Gray SM, Aylor KW, Barrett EJ. Unravelling the regulation of insulin transport across the brain endothelial cell. Diabetologia. 2017;60:1512–1521. doi: 10.1007/s00125-017-4285-4CrossrefPubMedGoogle Scholar147.Jais A, Solas M, Backes H, Chaurasia B, Kleinridders A, Theurich S, Mauer J, Steculorum SM, Hampel B, Goldau J, et al. Myeloid-cell-derived VEGF maintains brain glucose uptake and limits cognitive impairment in obesity. Cell. 2016;165:882–895. doi: 10.1016/j.cell.2016.03.033CrossrefPubMedGoogle Scholar148.Ogata S, Ito S, Masuda T, Ohtsuki S. Changes of blood-brain barrier and brain parenchymal protein expression levels of mice under different insulin-resistance conditions induced by high-fat diet. Pharm Res. 2019;36:141. doi: 10.1007/s11095-019-2674-8CrossrefPubMedGoogle Scholar149.Liu J, Jahn LA, Fowler DE, Barrett EJ, Cao W, Liu Z. Free fatty acids induce insulin resistance in both cardiac and skeletal muscle microvasculature in humans. J Clin Endocrinol Metab. 2011;96:438–446. doi: 10.1210/jc.2010-1174CrossrefPubMedGoogle Scholar150.Sacharidou A, Chambliss KL, Peng J, Tanigaki K, Islam MN, Sirsi S, Lemoff A, Hoyt K, Mineo C, Shaul PW. Apolipoprotein E receptor 2 in endothelium promote glucose tolerance by mediating insulin delivery to skeletal muscle. Mol Metab. 2025;101:102238. doi: 10.1016/j.molmet.2025.102238CrossrefPubMedGoogle Scholar151.Hedman AC, Smith JM, Sacks DB. The biology of IQGAP proteins: beyond the cytoskeleton. EMBO Rep. 2015;16:427–446. doi: 10.15252/embr.201439834CrossrefPubMedGoogle ScholarShow all references
eLetterseLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article
Information & AuthorsInformationAuthorsInformationPublished In
Arteriosclerosis, Thrombosis, and Vascular BiologyVolume 46 • Number 2 • February 2026Page: e321545PubMed: 41342145Copyright© 2025 American Heart Association, Inc.VersionsYou are viewing the most recent version of this article.4 December 2025: Ahead of PrintHistoryPublished online: 4 December 2025Published in print: February 2026PermissionsRequest permissions for this article.Request permissionsKeywordsendothelial cellsendothelium, vascularhyperglycemiainsulinmuscle fibers, skeletalSubjectsMetabolismAuthorsAffiliationsExpand AllChieko Mineo https://orcid.org/0000-0002-4978-6177Department of Pediatrics (C.M., P.W.S.), Center for Pulmonary and Vascular Biology, University of Texas Southwestern Medical Center, Dallas.Department of Cell Biology (C.M.), Center for Pulmonary and Vascular Biology, University of Texas Southwestern Medical Center, Dallas.View all articles by this authorPhilip W. Shaul https://orcid.org/0000-0003-1157-4002 philip.shaul@utsouthwestern.eduDepartment of Pediatrics (C.M., P.W.S.), Center for Pulmonary and Vascular Biology, University of Texas Southwestern Medical Center, Dallas.View all articles by this authorNotesATVB in Focus: Receptor-Mediated TranscytosisSeries Editor: Chieko MineoThis manuscript was sent to Katherine Gallagher, Handling Editor, for review by expert referees, editorial decision, and final disposition.For Sources of Funding and Disclosures, see page 287.Correspondence to: Philip W. Shaul, MD, Department of Pediatrics, Center for Pulmonary and Vascular Biology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390. Email philip.shaul@utsouthwestern.eduDisclosuresNone.Sources of FundingThe work is supported by the National Institutes of Health grants R01HL115122, R01HL144572, and R01HL144969 to P.W. Shaul.Metrics & CitationsMetricsCitationsMetrics
Article MetricsView all metricsDownloadsCitationsNo data available.020406080100120Dec 2025Jan 20261890TotalFirst 90 DaysTotal number of
downloads
See more details
On 1 Facebook pages
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Please select your download format:
RIS (ProCite, Reference Manager)
EndNote
BibTex
Medlars
RefWorks
Direct Import
FiguresOpen all in viewerGo to FigureOpen in ViewerTablesMediaShareShareShare article linkhttps://www.ahajournals.org/doi/pdf/10.1161/ATVBAHA.125.321545Copy LinkCopied!Copying failed.ShareFacebookLinkedInX (formerly Twitter)emailWeChatBlueskyGet AccessGet Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login
Institutional Login
Email
Password
Forgot your password? Reset it
here
Keep me logged in
Login
Don’t have an account? Register
here
Save for later
Item saved, go to cart
Purchase Options
Purchase this article to access the full text.
Purchase access to this article for 24 hours
Regulation of Insulin Transcytosis Across Endothelium in Metabolic Health and Disease
Arteriosclerosis, Thrombosis, and Vascular Biology
Vol. 46
No. 2
pp. e323501-
USD
$35.00
Add to Cart
Checkout
Purchase access to this journal for 24 hours
Arteriosclerosis, Thrombosis, and Vascular Biology
Vol. 46
No. 2
pp. e323501-
USD
$40.00
Add to Cart
Checkout
Restore your content access
Enter your email address to restore your content access:
Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.
ReferencesReferencesReferences1.Roden M, Shulman GI. The integrative biology of type 2 diabetes. Nature. 2019;576:51–60. doi: 10.1038/s41586-019-1797-8CrossrefPubMedGoogle Scholar2.Lawal Y, Bello F, Kaoje YS. Prediabetes deserves more attention: a review. Clin Diabetes. 2020;38:328–338. doi: 10.2337/cd19-0101CrossrefPubMedGoogle Scholar3.Wasserman DH, Wang TJ, Brown NJ. The vasculature in prediabetes. Circ Res. 2018;122:1135–1150. doi: 10.1161/CIRCRESAHA.118.311912CrossrefPubMedGoogle Scholar4.Vincent MA, Clerk LH, Rattigan S, Clark MG, Barrett EJ. Active role for the vasculature in the delivery of insulin to skeletal muscle. Clin Exp Pharmacol Physiol. 2005;32:302–307. doi: 10.1111/j.1440-1681.2005.04188.xCrossrefPubMedGoogle Scholar5.White MF, Kahn CR. The insulin signaling system. J Biol Chem. 1994;269:1–4.CrossrefPubMedGoogle Scholar6.Long YC, Zierath JR. Influence of AMP-activated protein kinase and calcineurin on metabolic networks in skeletal muscle. Am J Physiol Endocrinol Metab. 2008;295:E545–E552. doi: 10.1152/ajpendo.90259.2008CrossrefPubMedGoogle Scholar7.DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214–E223. doi: 10.1152/ajpendo.1979.237.3.E214CrossrefPubMedGoogle Scholar8.DeFronzo RA, Ferrannini E, Hendler R, Felig P, Wahren J. Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes. 1983;32:35–45. doi: 10.2337/diab.32.1.35CrossrefPubMedGoogle Scholar9.Dawson D, Vincent MA, Barrett EJ, Kaul S, Clark A, Leong-Poi H, Lindner JR. Vascular recruitment in skeletal muscle during exercise and hyperinsulinemia assessed by contrast ultrasound. Am J Physiol Endocrinol Metab. 2002;282:E714–E720. doi: 10.1152/ajpendo.00373.2001CrossrefPubMedGoogle Scholar10.DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes. 1981;30:1000–1007. doi: 10.2337/diab.30.12.1000CrossrefPubMedGoogle Scholar11.Yang YJ, Hope ID, Ader M, Bergman RN. Insulin transport across capillaries is rate limiting for insulin action in dogs. J Clin Invest. 1989;84:1620–1628. doi: 10.1172/JCI114339CrossrefPubMedGoogle Scholar12.Yang YJ, Hope ID, Ader M, Bergman RN. Importance of transcapillary insulin transport to dynamics of insulin action after intravenous glucose. Am J Physiol. 1994;266:E17–E25. doi: 10.1152/ajpendo.1994.266.1.E17CrossrefPubMedGoogle Scholar13.Kolka CM, Bergman RN. The barrier within: endothelial transport of hormones. Physiology (Bethesda). 2012;27:237–247. doi: 10.1152/physiol.00012.2012CrossrefPubMedGoogle Scholar14.Kubota T, Kubota N, Kumagai H, Yamaguchi S, Kozono H, Takahashi T, Inoue M, Itoh S, Takamoto I, Sasako T, et al. Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle. Cell Metab. 2011;13:294–307. doi: 10.1016/j.cmet.2011.01.018CrossrefPubMedGoogle Scholar15.Sjostrand M, Holmang A, Lonnroth P. Measurement of interstitial insulin in human muscle. Am J Physiol. 1999;276:E151–E154. doi: 10.1152/ajpendo.1999.276.1.E151CrossrefPubMedGoogle Scholar16.Sjostrand M, Holmang A, Strindberg L, Lonnroth P. Estimations of muscle interstitial insulin, glucose, and lactate in type 2 diabetic subjects. Am J Physiol Endocrinol Metab. 2000;279:E1097–E1103. doi: 10.1152/ajpendo.2000.279.5.E1097CrossrefPubMedGoogle Scholar17.McClatchey PM, Williams IM, Xu Z, Mignemi NA, Hughey CC, McGuinness OP, Beckman JA, Wasserman DH. Perfusion controls muscle glucose uptake by altering the rate of glucose dispersion in vivo. Am J Physiol Endocrinol Metab. 2019;317:E1022–E1036. doi: 10.1152/ajpendo.00260.2019CrossrefPubMedGoogle Scholar18.Akerstrom T, Goldman D, Nilsson F, Milkovich SL, Fraser GM, Brand CL, Hellsten Y, Ellis CG. Hyperinsulinemia does not cause de novo capillary recruitment in rat skeletal muscle. Microcirculation. 2020;27:e12593. doi: 10.1111/micc.12593CrossrefPubMedGoogle Scholar19.Williams IM, McClatchey PM, Bracy DP, Bonner JS, Valenzuela FA, Wasserman DH. Transendothelial insulin transport is impaired in skeletal muscle capillaries of obese male mice. Obesity (Silver Spring). 2020;28:303–314. doi: 10.1002/oby.22683CrossrefPubMedGoogle Scholar20.Williams IM, Valenzuela FA, Kahl SD, Ramkrishna D, Mezo AR, Young JD, Wells KS, Wasserman DH. Insulin exits skeletal muscle capillaries by fluid-phase transport. J Clin Invest. 2018;128:699–714. doi: 10.1172/JCI94053CrossrefPubMedGoogle Scholar21.Broussard JL, Castro AV, Iyer M, Paszkiewicz RL, Bediako IA, Szczepaniak LS, Szczepaniak EW, Bergman RN, Kolka CM. Insulin access to skeletal muscle is impaired during the early stages of diet-induced obesity. Obesity (Silver Spring). 2016;24:1922–1928. doi: 10.1002/oby.21562CrossrefPubMedGoogle Scholar22.Kolka CM, Bergman RN. The endothelium in diabetes: its role in insulin access and diabetic complications. Rev Endocr Metab Disord. 2013;14:13–19. doi: 10.1007/s11154-012-9233-5CrossrefPubMedGoogle Scholar23.Kolka CM, Harrison LN, Lottati M, Chiu JD, Kirkman EL, Bergman RN. Diet-induced obesity prevents interstitial dispersion of insulin in skeletal muscle. Diabetes. 2010;59:619–626. doi: 10.2337/db09-0839CrossrefPubMedGoogle Scholar24.Lee WL, Klip A. Endothelial transcytosis of insulin: Does it contribute to insulin resistance? Physiology (Bethesda). 2016;31:336–345. doi: 10.1152/physiol.00010.2016CrossrefPubMedGoogle Scholar25.Sherwin RS, Kramer KJ, Tobin JD, Insel PA, Liljenquist JE, Berman M, Andres R. A model of the kinetics of insulin in man. J Clin Invest. 1974;53:1481–1492. doi: 10.1172/JCI107697CrossrefPubMedGoogle Scholar26.Chiu JD, Richey JM, Harrison LN, Zuniga E, Kolka CM, Kirkman E, Ellmerer M, Bergman RN. Direct administration of insulin into skeletal muscle reveals that the transport of insulin across the capillary endothelium limits the time course of insulin to activate glucose disposal. Diabetes. 2008;57:828–835. doi: 10.2337/db07-1444CrossrefPubMedGoogle Scholar27.Prager R, Wallace P, Olefsky JM. In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. J Clin Invest. 1986;78:472–481. doi: 10.1172/JCI112599CrossrefPubMedGoogle Scholar28.Turk D, Alzaid A, Dinneen S, Nair KS, Rizza R. The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues. J Clin Invest. 1995;95:755–762. doi: 10.1172/JCI117723CrossrefPubMedGoogle Scholar29.Sjostrand M, Gudbjornsdottir S, Holmang A, Lonn L, Strindberg L, Lonnroth P. Delayed transcapillary transport of insulin to muscle interstitial fluid in obese subjects. Diabetes. 2002;51:2742–2748. doi: 10.2337/diabetes.51.9.2742CrossrefPubMedGoogle Scholar30.Sandqvist M, Strindberg L, Schmelz M, Lonnroth P, Jansson PA. Impaired delivery of insulin to adipose tissue and skeletal muscle in obese women with postprandial hyperglycemia. J Clin Endocrinol Metab. 2011;96:E1320–E1324. doi: 10.1210/jc.2011-0233CrossrefPubMedGoogle Scholar31.Barrett EJ, Wang H, Upchurch CT, Liu Z. Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature. Am J Physiol Endocrinol Metab. 2011;301:E252–E263. doi: 10.1152/ajpendo.00186.2011CrossrefPubMedGoogle Scholar32.Kubota T, Kubota N, Kadowaki T. The role of endothelial insulin signaling in the regulation of glucose metabolism. Rev Endocr Metab Disord. 2013;14:207–216. doi: 10.1007/s11154-013-9242-zCrossrefPubMedGoogle Scholar33.Williams IM, Wasserman DH. Capillary endothelial insulin transport: the rate-limiting step for insulin-stimulated glucose uptake. Endocrinology. 2022;163:bqab252. doi: 10.1210/endocr/bqab252CrossrefPubMedGoogle Scholar34.Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest. 1990;85:1844–1852. doi: 10.1172/JCI114644CrossrefPubMedGoogle Scholar35.Laakso M, Edelman SV, Brechtel G, Baron AD. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes. 1992;41:1076–1083. doi: 10.2337/diab.41.9.1076CrossrefPubMedGoogle Scholar36.Duplain H, Burcelin R, Sartori C, Cook S, Egli M, Lepori M, Vollenweider P, Pedrazzini T, Nicod P, Thorens B, et al. Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation. 2001;104:342–345. doi: 10.1161/01.cir.104.3.342CrossrefPubMedGoogle Scholar37.Wallis MG, Wheatley CM, Rattigan S, Barrett EJ, Clark AD, Clark MG. Insulin-mediated hemodynamic changes are impaired in muscle of Zucker obese rats. Diabetes. 2002;51:3492–3498. doi: 10.2337/diabetes.51.12.3492CrossrefPubMedGoogle Scholar38.Halseth AE, Bracy DP, Wasserman DH. Limitations to basal and insulin-stimulated skeletal muscle glucose uptake in the high-fat-fed rat. Am J Physiol Endocrinol Metab. 2000;279:E1064–E1071. doi: 10.1152/ajpendo.2000.279.5.E1064CrossrefPubMedGoogle Scholar39.Clark MG. Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle. Am J Physiol Endocrinol Metab. 2008;295:E732–E750. doi: 10.1152/ajpendo.90477.2008CrossrefPubMedGoogle Scholar40.Barrett EJ, Eggleston EM, Inyard AC, Wang H, Li G, Chai W, Liu Z. The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action. Diabetologia. 2009;52:752–764. doi: 10.1007/s00125-009-1313-zCrossrefPubMedGoogle Scholar41.Vincent MA, Dawson D, Clark AD, Lindner JR, Rattigan S, Clark MG, Barrett EJ. Skeletal muscle microvascular recruitment by physiological hyperinsulinemia precedes increases in total blood flow. Diabetes. 2002;51:42–48. doi: 10.2337/diabetes.51.1.42CrossrefPubMedGoogle Scholar42.Miles PD, Levisetti M, Reichart D, Khoursheed M, Moossa AR, Olefsky JM. Kinetics of insulin action in vivo. Identification of rate-limiting steps. Diabetes. 1995;44:947–953. doi: 10.2337/diab.44.8.947CrossrefPubMedGoogle Scholar43.Oezdemir I, Peng J, Ghosh D, Sirsi S, Mineo C, Shaul PW, Hoyt K. Multiscale and morphological analysis of microvascular patterns depicted in contrast-enhanced ultrasound images. J Med Imaging (Bellingham). 2020;7:034001. doi: 10.1117/1.JMI.7.3.034001CrossrefPubMedGoogle Scholar44.Aird WC. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res. 2007;100:174–190. doi: 10.1161/01.RES.0000255690.03436.aeCrossrefPubMedGoogle Scholar45.Aird WC. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res. 2007;100:158–173. doi: 10.1161/01.RES.0000255691.76142.4aCrossrefPubMedGoogle Scholar46.Azizi PM, Zyla RE, Guan S, Wang C, Liu J, Bolz SS, Heit B, Klip A, Lee WL. Clathrin-dependent entry and vesicle-mediated exocytosis define insulin transcytosis across microvascular endothelial cells. Mol Biol Cell. 2015;26:740–750. doi: 10.1091/mbc.E14-08-1307CrossrefPubMedGoogle Scholar47.Fung KYY, Fairn GD, Lee WL. Transcellular vesicular transport in epithelial and endothelial cells: challenges and opportunities. Traffic. 2018;19:5–18. doi: 10.1111/tra.12533CrossrefPubMedGoogle Scholar48.Sanwal R, Khosraviani N, Advani SL, Advani A, Lee WL. The endothelial barrier is not rate-limiting to insulin action in the myocardium of male mice. Endocrinology. 2020;161:bqaa029. doi: 10.1210/endocr/bqaa029CrossrefPubMedGoogle Scholar49.Yazdani S, Jaldin-Fincati JR, Pereira RVS, Klip A. Endothelial cell barriers: transport of molecules between blood and tissues. Traffic. 2019;20:390–403. doi: 10.1111/tra.12645CrossrefPubMedGoogle Scholar50.King GL, Johnson SM. Receptor-mediated transport of insulin across endothelial cells. Science. 1985;227:1583–1586. doi: 10.1126/science.3883490CrossrefPubMedGoogle Scholar51.Dernovsek KD, Bar RS. Processing of cell-bound insulin by capillary and macrovascular endothelial cells in culture. Am J Physiol. 1985;248:E244–E251. doi: 10.1152/ajpendo.1985.248.2.E244CrossrefPubMedGoogle Scholar52.Schnitzer JE, Oh P, Pinney E, Allard J. Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J Cell Biol. 1994;127:1217–1232. doi: 10.1083/jcb.127.5.1217CrossrefPubMedGoogle Scholar53.Wang H, Liu Z, Li G, Barrett EJ. The vascular endothelial cell mediates insulin transport into skeletal muscle. Am J Physiol Endocrinol Metab. 2006;291:E323–E332. doi: 10.1152/ajpendo.00047.2006CrossrefPubMedGoogle Scholar54.Li G, Barrett EJ, Wang H, Chai W, Liu Z. Insulin at physiological concentrations selectively activates insulin but not insulin-like growth factor I (IGF-I) or insulin/IGF-I hybrid receptors in endothelial cells. Endocrinology. 2005;146:4690–4696. doi: 10.1210/en.2005-0505CrossrefPubMedGoogle Scholar55.Yu Y, Kastin AJ, Pan W. Reciprocal interactions of insulin and insulin-like growth factor I in receptor-mediated transport across the blood-brain barrier. Endocrinology. 2006;147:2611–2615. doi: 10.1210/en.2006-0020CrossrefPubMedGoogle Scholar56.Majumdar S, Genders AJ, Inyard AC, Frison V, Barrett EJ. Insulin entry into muscle involves a saturable process in the vascular endothelium. Diabetologia. 2012;55:450–456. doi: 10.1007/s00125-011-2343-xCrossrefPubMedGoogle Scholar57.Steil GM, Ader M, Moore DM, Rebrin K, Bergman RN. Transendothelial insulin transport is not saturable in vivo. No evidence for a receptor-mediated process. J Clin Invest. 1996;97:1497–1503. doi: 10.1172/JCI118572CrossrefPubMedGoogle Scholar58.Hamilton-Wessler M, Ader M, Dea MK, Moore D, Loftager M, Markussen J, Bergman RN. Mode of transcapillary transport of insulin and insulin analog NN304 in dog hindlimb: evidence for passive diffusion. Diabetes. 2002;51:574–582. doi: 10.2337/diabetes.51.3.574CrossrefPubMedGoogle Scholar59.Konishi M, Sakaguchi M, Lockhart SM, Cai W, Li ME, Homan EP, Rask-Madsen C, Kahn CR. Endothelial insulin receptors differentially control insulin signaling kinetics in peripheral tissues and brain of mice. Proc Natl Acad Sci USA. 2017;114:E8478–E8487. doi: 10.1073/pnas.1710625114CrossrefPubMedGoogle Scholar60.Cogger VC, McNerney GP, Nyunt T, DeLeve LD, McCourt P, Smedsrod B, Le Couteur DG, Huser TR. Three-dimensional structured illumination microscopy of liver sinusoidal endothelial cell fenestrations. J Struct Biol. 2010;171:382–388. doi: 10.1016/j.jsb.2010.06.001CrossrefPubMedGoogle Scholar61.Duckworth WC, Bennett RG, Hamel FG. Insulin degradation: progress and potential. Endocr Rev. 1998;19:608–624. doi: 10.1210/edrv.19.5.0349CrossrefPubMedGoogle Scholar62.Wang H, Wang AX, Liu Z, Barrett EJ. Insulin signaling stimulates insulin transport by bovine aortic endothelial cells. Diabetes. 2008;57:540–547. doi: 10.2337/db07-0967CrossrefPubMedGoogle Scholar63.Wang H, Wang AX, Barrett EJ. Insulin-induced endothelial cell cortical actin filament remodeling: a requirement for trans-endothelial insulin transport. Mol Endocrinol. 2012;26:1327–1338. doi: 10.1210/me.2012-1003CrossrefPubMedGoogle Scholar64.Muniyappa R, Montagnani M, Koh KK, Quon MJ. Cardiovascular actions of insulin. Endocr Rev. 2007;28:463–491. doi: 10.1210/er.2007-0006CrossrefPubMedGoogle Scholar65.Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 1999;399:601–605. doi: 10.1038/21224CrossrefPubMedGoogle Scholar66.Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest. 1996;98:894–898. doi: 10.1172/JCI118871CrossrefPubMedGoogle Scholar67.Zeng G, Nystrom FH, Ravichandran LV, Cong LN, Kirby M, Mostowski H, Quon MJ. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation. 2000;101:1539–1545. doi: 10.1161/01.cir.101.13.1539CrossrefPubMedGoogle Scholar68.Montagnani M, Golovchenko I, Kim I, Koh GY, Goalstone ML, Mundhekar AN, Johansen M, Kucik DF, Quon MJ, Draznin B. Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. J Biol Chem. 2002;277:1794–1799. doi: 10.1074/jbc.M103728200CrossrefPubMedGoogle Scholar69.Cardillo C, Nambi SS, Kilcoyne CM, Choucair WK, Katz A, Quon MJ, Panza JA. Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation. 1999;100:820–825. doi: 10.1161/01.cir.100.8.820CrossrefPubMedGoogle Scholar70.Vincent MA, Barrett EJ, Lindner JR, Clark MG, Rattigan S. Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am J Physiol Endocrinol Metab. 2003;285:E123–E129. doi: 10.1152/ajpendo.00021.2003CrossrefPubMedGoogle Scholar71.Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin’s vascular effects in humans. J Clin Invest. 1994;94:2511–2515. doi: 10.1172/JCI117621CrossrefPubMedGoogle Scholar72.Kainoh M, Maruyama I, Nishio S, Nakadate T. Enhancement by beraprost sodium, a stable analogue of prostacyclin, in thrombomodulin expression on membrane surface of cultured vascular endothelial cells via increase in cyclic AMP level. Biochem Pharmacol. 1991;41:1135–1140. doi: 10.1016/0006-2952(91)90651-kCrossrefPubMedGoogle Scholar73.Niwano K, Arai M, Tomaru K, Uchiyama T, Ohyama Y, Kurabayashi M. Transcriptional stimulation of the eNOS gene by the stable prostacyclin analogue beraprost is mediated through cAMP-responsive element in vascular endothelial cells: close link between PGI2 signal and NO pathways. Circ Res. 2003;93:523–530. doi: 10.1161/01.RES.0000091336.55487.F7CrossrefPubMedGoogle Scholar74.Lievre M, Morand S, Besse B, Fiessinger JN, Boissel JP. Oral Beraprost sodium, a prostaglandin I(2) analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial. Beraprost et Claudication Intermittente (BERCI) Research Group. Circulation. 2000;102:426–431. doi: 10.1161/01.cir.102.4.426CrossrefPubMedGoogle Scholar75.Galie N, Humbert M, Vachiery JL, Vizza CD, Kneussl M, Manes A, Sitbon O, Torbicki A, Delcroix M, Naeije R, et al; Arterial Pulmonary Hypertension and Beraprost European (ALPHABET) Study Group. Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol. 2002;39:1496–1502. doi: 10.1016/s0735-1097(02)01786-2CrossrefPubMedGoogle Scholar76.Ayala JE, Bracy DP, Julien BM, Rottman JN, Fueger PT, Wasserman DH. Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice. Diabetes. 2007;56:1025–1033. doi: 10.2337/db06-0883CrossrefPubMedGoogle Scholar77.Chai W, Fu Z, Aylor KW, Barrett EJ, Liu Z. Liraglutide prevents microvascular insulin resistance and preserves muscle capillary density in high-fat diet-fed rats. Am J Physiol Endocrinol Metab. 2016;311:E640–E648. doi: 10.1152/ajpendo.00205.2016CrossrefPubMedGoogle Scholar78.Bonner JS, Lantier L, Hocking KM, Kang L, Owolabi M, James FD, Bracy DP, Brophy CM, Wasserman DH. Relaxin treatment reverses insulin resistance in mice fed a high-fat diet. Diabetes. 2013;62:3251–3260. doi: 10.2337/db13-0033CrossrefPubMedGoogle Scholar79.Baron AD, Tarshoby M, Hook G, Lazaridis EN, Cronin J, Johnson A, Steinberg HO. Interaction between insulin sensitivity and muscle perfusion on glucose uptake in human skeletal muscle: evidence for capillary recruitment. Diabetes. 2000;49:768–774. doi: 10.2337/diabetes.49.5.768CrossrefPubMedGoogle Scholar80.Jansson PA, Murdolo G, Sjogren L, Nystrom B, Sjostrand M, Strindberg L, Lonnroth P. Tadalafil increases muscle capillary recruitment and forearm glucose uptake in women with type 2 diabetes. Diabetologia. 2010;53:2205–2208. doi: 10.1007/s00125-010-1819-4CrossrefPubMedGoogle Scholar81.Wang H, Wang AX, Aylor K, Barrett EJ. Nitric oxide directly promotes vascular endothelial insulin transport. Diabetes. 2013;62:4030–4042. doi: 10.2337/db13-0627CrossrefPubMedGoogle Scholar82.Mauvais-Jarvis F, Clegg DJ, Hevener AL. The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev. 2013;34:309–338. doi: 10.1210/er.2012-1055CrossrefPubMedGoogle Scholar83.Hevener AL, Clegg DJ, Mauvais-Jarvis F. Impaired estrogen receptor action in the pathogenesis of the metabolic syndrome. Mol Cell Endocrinol. 2015;418 Pt 3:306–321. doi: 10.1016/j.mce.2015.05.020CrossrefPubMedGoogle Scholar84.Wagner JD, Thomas MJ, Williams JK, Zhang L, Greaves KA, Cefalu WT. Insulin sensitivity and cardiovascular risk factors in ovariectomized monkeys with estradiol alone or combined with nomegestrol acetate. J Clin Endocrinol Metab. 1998;83:896–901. doi: 10.1210/jcem.83.3.4628CrossrefPubMedGoogle Scholar85.Kumagai S, Holmang A, Bjorntorp P. The effects of oestrogen and progesterone on insulin sensitivity in female rats. Acta Physiol Scand. 1993;149:91–97. doi: 10.1111/j.1748-1716.1993.tb09596.xCrossrefPubMedGoogle Scholar86.Riant E, Waget A, Cogo H, Arnal JF, Burcelin R, Gourdy P. Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology. 2009;150:2109–2117. doi: 10.1210/en.2008-0971CrossrefPubMedGoogle Scholar87.Osborne CK, Schiff R. Estrogen-receptor biology: continuing progress and therapeutic implications. J Clin Oncol. 2005;23:1616–1622. doi: 10.1200/JCO.2005.10.036CrossrefPubMedGoogle Scholar88.Musatov S, Chen W, Pfaff DW, Mobbs CV, Yang XJ, Clegg DJ, Kaplitt MG, Ogawa S. Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proc Natl Acad Sci USA. 2007;104:2501–2506. doi: 10.1073/pnas.0610787104CrossrefPubMedGoogle Scholar89.Bryzgalova G, Lundholm L, Portwood N, Gustafsson JA, Khan A, Efendic S, Dahlman-Wright K. Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice. Am J Physiol Endocrinol Metab. 2008;295:E904–E912. doi: 10.1152/ajpendo.90248.2008CrossrefPubMedGoogle Scholar90.Ropero AB, Alonso-Magdalena P, Quesada I, Nadal A. The role of estrogen receptors in the control of energy and glucose homeostasis. Steroids. 2008;73:874–879. doi: 10.1016/j.steroids.2007.12.018CrossrefPubMedGoogle Scholar91.Barros R, Gabbi C, Morani A, Warner M, Gustafsson JA. Participation of ER{alpha} and ER{beta} in glucose homeostasis in skeletal muscle and white adipose tissue. Am J Physiol Endocrinol Metab. 2009;297:E124. doi: 10.1152/ajpendo.00189.2009CrossrefPubMedGoogle Scholar92.Davis KE, Neinast D, Sun K, Skiles M, Bills D, Zehr A, Zeve D, Hahner D, Cox W, Gent M, et al. The sexually dimorphic role of adipose and adipocyte estrogen receptors in modulating adipose tissue expansion, inflammation, and fibrosis. Mol Metab. 2013;2:227–242. doi: 10.1016/j.molmet.2013.05.006CrossrefPubMedGoogle Scholar93.Ribas V, Drew BG, Le JA, Soleymani T, Daraei P, Sitz D, Mohammad L, Henstridge DC, Febbraio MA, Hewitt SC, et al. Myeloid-specific estrogen receptor {alpha} deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development. Proc Natl Acad Sci USA. 2011;108:16457–16462. doi: 10.1073/pnas.1104533108CrossrefPubMedGoogle Scholar94.Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci USA. 2000;97:12729–12734. doi: 10.1073/pnas.97.23.12729CrossrefPubMedGoogle Scholar95.Bryzgalova G, Gao H, Ahren B, Zierath JR, Galuska D, Steiler TL, Dahlman-Wright K, Nilsson S, Gustafsson JA, Efendic S, et al. Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia. 2006;49:588–597. doi: 10.1007/s00125-005-0105-3CrossrefPubMedGoogle Scholar96.Heianza Y, Arase Y, Kodama S, Hsieh SD, Tsuji H, Saito K, Shimano H, Hara S, Sone H. Effect of postmenopausal status and age at menopause on type 2 diabetes and prediabetes in Japanese individuals: Toranomon Hospital Health Management Center Study 17 (TOPICS 17). Diabetes Care. 2013;36:4007–4014. doi: 10.2337/dc13-1048CrossrefPubMedGoogle Scholar97.Gurka MJ, Vishnu A, Santen RJ, DeBoer MD. Progression of metabolic syndrome severity during the menopausal transition. J Am Heart Assoc. 2016;5:e003609. doi: 10.1161/JAHA.116.003609CrossrefPubMedGoogle Scholar98.Szmuilowicz ED, Stuenkel CA, Seely EW. Influence of menopause on diabetes and diabetes risk. Nat Rev Endocrinol. 2009;5:553–558. doi: 10.1038/nrendo.2009.166CrossrefPubMedGoogle Scholar99.Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 1994;331:1056–1061. doi: 10.1056/NEJM199410203311604CrossrefPubMedGoogle Scholar100.Maffei L, Murata Y, Rochira V, Tubert G, Aranda C, Vazquez M, Clyne CD, Davis S, Simpson ER, Carani C. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab. 2004;89:61–70. doi: 10.1210/jc.2003-030313CrossrefPubMedGoogle Scholar101.Rochira V, Madeo B, Zirilli L, Caffagni G, Maffei L, Carani C. Oestradiol replacement treatment and glucose homeostasis in two men with congenital aromatase deficiency: evidence for a role of oestradiol and sex steroids imbalance on insulin sensitivity in men. Diabet Med. 2007;24:1491–1495. doi: 10.1111/j.1464-5491.2007.02304.xCrossrefPubMedGoogle Scholar102.Takeda K, Toda K, Saibara T, Nakagawa M, Saika K, Onishi T, Sugiura T, Shizuta Y. Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J Endocrinol. 2003;176:237–246. doi: 10.1677/joe.0.1760237CrossrefPubMedGoogle Scholar103.Chambliss KL, Shaul PW. Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev. 2002;23:665–686. doi: 10.1210/er.2001-0045CrossrefPubMedGoogle Scholar104.Levin ER. Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol. 2005;19:1951–1959. doi: 10.1210/me.2004-0390CrossrefPubMedGoogle Scholar105.Lantin-Hermoso RL, Rosenfeld CR, Yuhanna IS, German Z, Chen Z, Shaul PW. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am J Physiol. 1997;273:L119–L126. doi: 10.1152/ajplung.1997.273.1.L119CrossrefPubMedGoogle Scholar106.Chambliss KL, Yuhanna IS, Mineo C, Liu P, German Z, Sherman TS, Mendelsohn ME, Anderson RG, Shaul PW. Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circ Res. 2000;87:E44–E52. doi: 10.1161/01.res.87.11.e44CrossrefPubMedGoogle Scholar107.Sacharidou A, Chambliss K, Peng J, Barrera J, Tanigaki K, Luby-Phelps K, Ozdemir I, Khan S, Sirsi SR, Kim SH, et al. Endothelial ERalpha promotes glucose tolerance by enhancing endothelial insulin transport to skeletal muscle. Nat Commun. 2023;14:4989. doi: 10.1038/s41467-023-40562-wCrossrefPubMedGoogle Scholar108.Gu P, Xu A. Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction. Rev Endocr Metab Disord. 2013;14:49–58. doi: 10.1007/s11154-012-9230-8CrossrefPubMedGoogle Scholar109.Scalia R. The microcirculation in adipose tissue inflammation. Rev Endocr Metab Disord. 2013;14:69–76. doi: 10.1007/s11154-013-9236-xCrossrefPubMedGoogle Scholar110.Chambliss KL, Wu Q, Oltmann S, Konaniah ES, Umetani M, Korach KS, Thomas GD, Mineo C, Yuhanna IS, Kim SH, et al. Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J Clin Invest. 2010;120:2319–2330. doi: 10.1172/JCI38291CrossrefPubMedGoogle Scholar111.Lu Q, Schnitzler GR, Ueda K, Iyer LK, Diomede OI, Andrade T, Karas RH. ER alpha rapid signaling is required for estrogen induced proliferation and migration of vascular endothelial cells. PLoS One. 2016;11:e0152807. doi: 10.1371/journal.pone.0152807CrossrefPubMedGoogle Scholar112.Nilsson BO. Modulation of the inflammatory response by estrogens with focus on the endothelium and its interactions with leukocytes. Inflamm Res. 2007;56:269–273. doi: 10.1007/s00011-007-6198-zCrossrefPubMedGoogle Scholar113.Teasdale RD, Loci D, Houghton F, Karlsson L, Gleeson PA. A large family of endosome-localized proteins related to sorting nexin 1. Biochem J. 2001;358:7–16. doi: 10.1042/0264-6021:3580007CrossrefGoogle Scholar114.Worby CA, Dixon JE. Sorting out the cellular functions of sorting nexins. Nat Rev Mol Cell Biol. 2002;3:919–931. doi: 10.1038/nrm974CrossrefPubMedGoogle Scholar115.Haft CR, de la Luz SM, Barr VA, Haft DH, Taylor SI. Identification of a family of sorting nexin molecules and characterization of their association with receptors. Mol Cell Biol. 1998;18:7278–7287. doi: 10.1128/mcb.18.12.7278CrossrefPubMedGoogle Scholar116.Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881–887. doi: 10.1038/nature05488CrossrefPubMedGoogle Scholar117.Rabinowitz D, Zierler KL. Forearm metabolism in obesity and its response to intra-arterial insulin. Characterization of insulin resistance and evidence for adaptive hyperinsulinism. J Clin Invest. 1962;41:2173–2181. doi: 10.1172/JCI104676CrossrefPubMedGoogle Scholar118.DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care. 2009;32:S157–S163. doi: 10.2337/dc09-S302CrossrefPubMedGoogle Scholar119.Gudbjornsdottir S, Sjostrand M, Strindberg L, Wahren J, Lonnroth P. Direct measurements of the permeability surface area for insulin and glucose in human skeletal muscle. J Clin Endocrinol Metab. 2003;88:4559–4564. doi: 10.1210/jc.2003-030434CrossrefPubMedGoogle Scholar120.Bergman RN. Insulin action and distribution of tissue blood flow. J Clin Endocrinol Metab. 2003;88:4556–4558. doi: 10.1210/jc.2003-031431CrossrefPubMedGoogle Scholar121.Pillon NJ, Azizi PM, Li YE, Liu J, Wang C, Chan KL, Hopperton KE, Bazinet RP, Heit B, Bilan PJ, et al. Palmitate-induced inflammatory pathways in human adipose microvascular endothelial cells promote monocyte adhesion and impair insulin transcytosis. Am J Physiol Endocrinol Metab. 2015;309:E35–E44. doi: 10.1152/ajpendo.00611.2014CrossrefPubMedGoogle Scholar122.Winer DA, Winer S, Shen L, Wadia PP, Yantha J, Paltser G, Tsui H, Wu P, Davidson MG, Alonso MN, et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med. 2011;17:610–617. doi: 10.1038/nm.2353CrossrefPubMedGoogle Scholar123.Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017;127:1–4. doi: 10.1172/JCI92035CrossrefPubMedGoogle Scholar124.Tanigaki K, Vongpatanasin W, Barrera JA, Atochin DN, Huang PL, Bonvini E, Shaul PW, Mineo C. C-reactive protein causes insulin resistance in mice through Fcgamma receptor IIB-mediated inhibition of skeletal muscle glucose delivery. Diabetes. 2013;62:721–731. doi: 10.2337/db12-0133CrossrefPubMedGoogle Scholar125.Tanigaki K, Chambliss KL, Yuhanna IS, Sacharidou A, Ahmed M, Atochin DN, Huang PL, Shaul PW, Mineo C. Endothelial Fcgamma receptor IIB activation blunts insulin delivery to skeletal muscle to cause insulin resistance in mice. Diabetes. 2016;65:1996–2005. doi: 10.2337/db15-1605CrossrefPubMedGoogle Scholar126.Ferrara C, Grau S, Jager C, Sondermann P, Brunker P, Waldhauer I, Hennig M, Ruf A, Rufer AC, Stihle M, et al. Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose. Proc Natl Acad Sci USA. 2011;108:12669–12674. doi: 10.1073/pnas.1108455108CrossrefPubMedGoogle Scholar127.Anthony RM, Wermeling F, Ravetch JV. Novel roles for the IgG Fc glycan. Ann N Y Acad Sci. 2012;1253:170–180. doi: 10.1111/j.1749-6632.2011.06305.xCrossrefPubMedGoogle Scholar128.Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol. 2008;8:34–47. doi: 10.1038/nri2206CrossrefPubMedGoogle Scholar129.Damelang T, Brinkhaus M, van Osch TLJ, Schuurman J, Labrijn AF, Rispens T, Vidarsson G. Impact of structural modifications of IgG antibodies on effector functions. Front Immunol. 2023;14:1304365. doi: 10.3389/fimmu.2023.1304365CrossrefPubMedGoogle Scholar130.Kristic J, Lauc G. The importance of IgG glycosylation-what did we learn after analyzing over 100,000 individuals. Immunol Rev. 2024;328:143–170. doi: 10.1111/imr.13407CrossrefPubMedGoogle Scholar131.Gudelj I, Lauc G, Pezer M. Immunoglobulin G glycosylation in aging and diseases. Cell Immunol. 2018;333:65–79. doi: 10.1016/j.cellimm.2018.07.009CrossrefPubMedGoogle Scholar132.Vattepu R, Sneed SL, Anthony RM. Sialylation as an important regulator of antibody function. Front Immunol. 2022;13:818736. doi: 10.3389/fimmu.2022.818736CrossrefPubMedGoogle Scholar133.Nikolac Perkovic M, Pucic Bakovic M, Kristic J, Novokmet M, Huffman JE, Vitart V, Hayward C, Rudan I, Wilson JF, Campbell H, et al. The association between galactosylation of immunoglobulin G and body mass index. Prog Neuropsychopharmacol Biol Psychiatry. 2014;48:20–25. doi: 10.1016/j.pnpbp.2013.08.014CrossrefPubMedGoogle Scholar134.Russell AC, Kepka A, Trbojevic-Akmacic I, Ugrina I, Song M, Hui J, Hunter M, Laws SM, Lauc G, Wang W. Increased central adiposity is associated with pro-inflammatory immunoglobulin G N-glycans. Immunobiology. 2019;224:110–115. doi: 10.1016/j.imbio.2018.10.002CrossrefPubMedGoogle Scholar135.Liu D, Li Q, Dong J, Li D, Xu X, Xing W, Zhang X, Cao W, Hou H, Wang H, et al. The association between normal BMI with central adiposity and proinflammatory potential immunoglobulin G N-glycosylation. Diabetes Metab Syndr Obes. 2019;12:2373–2385. doi: 10.2147/DMSO.S216318CrossrefPubMedGoogle Scholar136.Tanigaki K, Sacharidou A, Peng J, Chambliss KL, Yuhanna IS, Ghosh D, Ahmed M, Szalai AJ, Vongpatanasin W, Mattrey RF, et al. Hyposialylated IgG activates endothelial IgG receptor FcgammaRIIB to promote obesity-induced insulin resistance. J Clin Invest. 2018;128:309–322. doi: 10.1172/JCI89333CrossrefPubMedGoogle Scholar137.Solar P, Zamani A, Lakatosova K, Joukal M. The blood-brain barrier and the neurovascular unit in subarachnoid hemorrhage: molecular events and potential treatments. Fluids Barriers CNS. 2022;19:29. doi: 10.1186/s12987-022-00312-4CrossrefPubMedGoogle Scholar138.Engelhardt B, Sorokin L. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin Immunopathol. 2009;31:497–511. doi: 10.1007/s00281-009-0177-0CrossrefPubMedGoogle Scholar139.Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis. 2010;37:13–25. doi: 10.1016/j.nbd.2009.07.030CrossrefPubMedGoogle Scholar140.Bernacki J, Dobrowolska A, Nierwinska K, Malecki A. Physiology and pharmacological role of the blood-brain barrier. Pharmacol Rep. 2008;60:600–622.PubMedGoogle Scholar141.Andreone BJ, Chow BW, Tata A, Lacoste B, Ben-Zvi A, Bullock K, Deik AA, Ginty DD, Clish CB, Gu C. Blood-brain barrier permeability is regulated by lipid transport-dependent suppression of caveolae-mediated transcytosis. Neuron. 2017;94:581–594.e5. doi: 10.1016/j.neuron.2017.03.043CrossrefPubMedGoogle Scholar142.Ohtsuki S. Insulin receptor at the blood-brain barrier: transport and signaling. Vitam Horm. 2024;126:113–124. doi: 10.1016/bs.vh.2024.05.001CrossrefPubMedGoogle Scholar143.Pomytkin I, Costa-Nunes JP, Kasatkin V, Veniaminova E, Demchenko A, Lyundup A, Lesch KP, Ponomarev ED, Strekalova T. Insulin receptor in the brain: mechanisms of activation and the role in the CNS pathology and treatment. CNS Neurosci Ther. 2018;24:763–774. doi: 10.1111/cns.12866CrossrefPubMedGoogle Scholar144.Rhea EM, Rask-Madsen C, Banks WA. Insulin transport across the blood-brain barrier can occur independently of the insulin receptor. J Physiol. 2018;596:4753–4765. doi: 10.1113/JP276149CrossrefPubMedGoogle Scholar145.Akhtar A, Sah SP. Insulin signaling pathway and related molecules: role in neurodegeneration and Alzheimer’s disease. Neurochem Int. 2020;135:104707. doi: 10.1016/j.neuint.2020.104707CrossrefPubMedGoogle Scholar146.Gray SM, Aylor KW, Barrett EJ. Unravelling the regulation of insulin transport across the brain endothelial cell. Diabetologia. 2017;60:1512–1521. doi: 10.1007/s00125-017-4285-4CrossrefPubMedGoogle Scholar147.Jais A, Solas M, Backes H, Chaurasia B, Kleinridders A, Theurich S, Mauer J, Steculorum SM, Hampel B, Goldau J, et al. Myeloid-cell-derived VEGF maintains brain glucose uptake and limits cognitive impairment in obesity. Cell. 2016;165:882–895. doi: 10.1016/j.cell.2016.03.033CrossrefPubMedGoogle Scholar148.Ogata S, Ito S, Masuda T, Ohtsuki S. Changes of blood-brain barrier and brain parenchymal protein expression levels of mice under different insulin-resistance conditions induced by high-fat diet. Pharm Res. 2019;36:141. doi: 10.1007/s11095-019-2674-8CrossrefPubMedGoogle Scholar149.Liu J, Jahn LA, Fowler DE, Barrett EJ, Cao W, Liu Z. Free fatty acids induce insulin resistance in both cardiac and skeletal muscle microvasculature in humans. J Clin Endocrinol Metab. 2011;96:438–446. doi: 10.1210/jc.2010-1174CrossrefPubMedGoogle Scholar150.Sacharidou A, Chambliss KL, Peng J, Tanigaki K, Islam MN, Sirsi S, Lemoff A, Hoyt K, Mineo C, Shaul PW. Apolipoprotein E receptor 2 in endothelium promote glucose tolerance by mediating insulin delivery to skeletal muscle. Mol Metab. 2025;101:102238. doi: 10.1016/j.molmet.2025.102238CrossrefPubMedGoogle Scholar151.Hedman AC, Smith JM, Sacks DB. The biology of IQGAP proteins: beyond the cytoskeleton. EMBO Rep. 2015;16:427–446. doi: 10.15252/embr.201439834CrossrefPubMedGoogle Scholar
Advertisement
RecommendedApril 2018Abstract 308: Losartan Increases Muscle Insulin Delivery via Microvascular Recruitment and Rescues Insulin’s Metabolic Action during Lipid Infusion
Nasui Wang,
Weidong Chai,
Lina Zhao, and
[...]Zhenqi Liu
+0 authors
March 2020Association of Insulin Resistance, Plasma Glucose Level, and Serum Insulin Level With Hypertension in a Population With Different Stages of Impaired Glucose Metabolism
Nobuo Sasaki,
Ryoji Ozono,
Yukihito Higashi,
Ryo Maeda, and
[...]Yasuki Kihara
+1 authors
March 2018Abstract 18130: Acute Changes of Glucose and Insulin Levels During Oral Glucose Tolerance Test are Related to Changes in Arterial Stiffness and Wave Reflection
Ignatios Ikonomidis,
Charis Koukoulis,
Vasiliki Lambadiari,
Fotini Spanoudi,
Stavros Tzortzis,
Vlassis Tritakis,
Helen Triantafyllidi,
John Lekakis,
Georgios Dimitriadis, and
[...]Maria Anastasiou-Nana
+6 authors
Advertisement
Submit a Response to This ArticleCloseCompose eLetterTitle:Comment text:Contributors(all fields are required)Remove ContributorFirst Name:Last Name:Email:Affiliation:Add Another Contributor
Statement of Competing InterestsCompeting Interests?YESNOPlease describe the competing interests
CancelSubmitView full text|Download PDF
Comment Response
Arteriosclerosis, Thrombosis, and Vascular Biology
Submit
Browse
Browse
Collections
Subject Terms
AHA Journal Podcasts
Trend Watch
Resources
Resources
CME
Journal Metrics
Early Career Resources
AHA Journals @ Meetings
Information
Information
For Authors
For Reviewers
For Subscribers
For International Users
Arteriosclerosis, Thrombosis, and Vascular Biology
Circulation
Circulation Research
Hypertension
Stroke
Journal of the American Heart Association
Circulation: Arrhythmia and Electrophysiology
Circulation: Cardiovascular Imaging
Circulation: Cardiovascular Interventions
Circulation: Population Health and Outcomes
Circulation: Genomic and Precision Medicine
Circulation: Heart Failure
Stroke: Vascular and Interventional Neurology
Annals of Internal Medicine: Clinical Cases
This page is managed by Wolters Kluwer Health, Inc. and/or its affiliates or subsidiaries. Wolters Kluwer Privacy Policy
Your California Privacy Choices
Manage Cookie Preferences
Back to top
National Center
7272 Greenville Ave.Dallas, TX 75231Customer Service
1-800-AHA-USA-1
1-800-242-8721Hours
Monday - Friday: 7 a.m. – 7 p.m. CT
Saturday: 9 a.m. - 5 p.m. CT
Closed on SundaysTax Identification Number
13-5613797
ABOUT
US
About the
AHA/ASA
Annual
report
AHA Financial
Information
Careers
International
Programs
Latest Heart and
Stroke News
AHA/ASA Media
Newsroom
GET
INVOLVED
Donate
Advocate
Volunteer
ShopHeart
ShopCPR
OUR
SITES
American Heart
Association
American Stroke
Association
CPR &
ECC
Go Red For
Women
More
Sites
AHA Careers
AHA Privacy Policy
Medical Advice Disclaimer
Copyright Policy
Accessibility Statement
Ethics Policy
Conflict of Interes Policy
Linking Policy
Whistleblower Policy
Content Editorial Guidelines
Diversity
Suppliers & Providers
State Fundraising Notices
©2026 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.The
American Heart Association is a qualified 501(c)(3) tax-exempt organization.*Red Dress ™ DHHS, Go Red ™
AHA ; National Wear Red Day® is a registered trademark.
Copy link✓Thanks for sharing!Find any serviceAddToAnyMore…Privacy Preference CenterWhen you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device. Because we respect your right to privacy, you can choose not to allow certain types of cookies on our website. Click on the different category headings to find out more and manage your cookie preferences. However, blocking some types of cookies may impact your experience on the site and the services we are able to offer.
Privacy & Cookie NoticeManage Consent PreferencesStrictly Necessary CookiesAlways ActiveThese cookies are necessary for the website to function. They are usually set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, this may have an effect on the proper functioning of (parts of) the site.View Vendor Details‎Functional Cookies
Functional Cookies These cookies enable the website to provide enhanced functionality, user experience and personalization, and may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies, then some or all of these services may not function properly.View Vendor Details‎Performance Cookies
Performance Cookies These cookies support analytic services that measure and improve the performance of our site. They
help us know which pages are the most and least popular and see how visitors move around the site.View Vendor Details‎Advertising Cookies
Advertising Cookies These cookies may collect insights to issue personalized content and advertising on our own and other websites, and may be set through our site by third party providers.
If you do not allow these cookies, you may still see basic advertising on your browser that is generic and not based on your interests.View Vendor Details‎Back ButtonVendors List Search IconFilter IconClear checkbox label labelApply CancelConsent Leg.Interest checkbox label label checkbox label label checkbox label labelAllow AllReject All Confirm My Choices
Now Reading:Regulation of Insulin Transcytosis Across Endothelium in Metabolic Health and DiseaseTrack CitationsAdd to favoritesShareGet AccessPREVIOUS ARTICLEEndothelial Cell Regulation of Lipid Uptake During Feeding and FastingPreviousNEXT ARTICLEMore Than a Cleanup Crew: The Expanding Biology of EfferocytosisNext__("articleCrossmark.closePopup")
